Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP150231)
National Institutes of Health (T32 CA186892-2)
- License Information
-
More Information
Article History
First Online: 26 March 2018
Competing interests
: The MD Anderson Cancer Center and RK hold patents in the area of exosome biology and are licensed to Codiak Biosciences Inc. The MD Anderson Cancer Center and RK are stock equity holders in Codiak Biosciences Inc. RK receives research support from Codiak Biosciences Inc. and serves as a member of the board of directors of this company. PK and JT declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
